Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (261-270 of 501) with videos related to

Pageof 51
Sort By:
Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.
The Journal of Investigative Dermatology|December 17, 2008
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomideTobias Sinnberg, Konstantinos Lasithiotakis, Heike Niessner, et al.
Melanoma Research|March 14, 2008
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological SocietySilke S Schwager, Ulrike Leiter, Petra G Buettner, et al.
Journal of the American Academy of Dermatology|June 25, 2011
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma RegistryUlrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Plos One|November 11, 2014
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanomaTarun Mehra, Gerd Grözinger, Steven Mann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Journal of Clinical Medicine|July 19, 2020
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance TrialsTheresa Steeb, Anja Wessely, Matthias Harlaß, et al.
Cancers|August 23, 2020
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and InvasionCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
The American Journal of Pathology|May 22, 2003
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survivalSoheil S Dadras, Thomas Paul, Jennifer Bertoncini, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Maria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Pageof 51

Showing results (261-270 of 501) with videos related to

Sort By:
Pageof 51
Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.
The Journal of Investigative Dermatology|December 17, 2008
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomideTobias Sinnberg, Konstantinos Lasithiotakis, Heike Niessner, et al.
Melanoma Research|March 14, 2008
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological SocietySilke S Schwager, Ulrike Leiter, Petra G Buettner, et al.
Journal of the American Academy of Dermatology|June 25, 2011
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma RegistryUlrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Plos One|November 11, 2014
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanomaTarun Mehra, Gerd Grözinger, Steven Mann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Journal of Clinical Medicine|July 19, 2020
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance TrialsTheresa Steeb, Anja Wessely, Matthias Harlaß, et al.
Cancers|August 23, 2020
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and InvasionCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
The American Journal of Pathology|May 22, 2003
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survivalSoheil S Dadras, Thomas Paul, Jennifer Bertoncini, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Maria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Pageof 51